ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.97 USD
6.2%
Updated:
Apr 24, 2024
ADC Therapeutics SA
Research & Development
Last
Value
3-Years CAGR
5-Years CAGR
|
ADC Therapeutics SA
Research & Development Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Research & Development
-$127.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Research & Development
-CHf54.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Research & Development
-$387.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Research & Development
-CHf77.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-4%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Research & Development
-CHf368.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Research & Development
-CHf2.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Research & Development?
Research & Development
-127.1m
USD
-127.1m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Research & Development amounts to -127.1m USD.
What is ADC Therapeutics SA's Research & Development growth rate?
Research & Development CAGR 5Y
-2%
-2%
Over the last year, the Research & Development growth was 32%. The average annual Research & Development growth rates for ADC Therapeutics SA have been 3% over the past three years , -2% over the past five years .
You don't have any saved screeners yet
